Ganglioneuroblastoma
Showing 1 - 18 of 18
Neuroblastoma, Ganglioneuroblastoma Trial in Moscow (monoclonal antibodies GD2)
Recruiting
- Neuroblastoma
- Ganglioneuroblastoma
- monoclonal antibodies GD2
-
Moscow, Russian FederationResearch Institute of Pediatric Hematology, Oncology and Immunol
Oct 4, 2023
Neuroblastoma, Ganglioneuroblastoma, Ganglioneuroma Trial (No Intervention NA)
Not yet recruiting
- Neuroblastoma
- +2 more
- No Intervention NA
- (no location specified)
Dec 31, 2021
Ganglioneuroblastoma, Ganglioneuroma, Metastatic Neuroblastoma Trial in Rochester (Computed Tomography, Gallium Ga 68-DOTATATE,
Recruiting
- Ganglioneuroblastoma
- +2 more
- Computed Tomography
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 30, 2023
Neuroblastoma, Ganglioneuroblastoma Trial in Boston (Proton Beam Radiation Therapy)
Recruiting
- Neuroblastoma
- Ganglioneuroblastoma
- Proton Beam Radiation Therapy
-
Boston, MassachusettsMassachusetts General Hospital
Jan 3, 2021
CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in
Active, not recruiting
- Central Nervous System Embryonal Tumor With Rhabdoid Features
- +14 more
- Adavosertib
- Irinotecan Hydrochloride
-
Birmingham, Alabama
- +23 more
Oct 7, 2022
Ganglioneuroblastoma, High Risk Neuroblastoma Trial in Australia, New Zealand, United States (procedure, drug, biological,
Active, not recruiting
- Ganglioneuroblastoma
- High Risk Neuroblastoma
- Autologous Hematopoietic Stem Cell Transplantation
- +14 more
-
Los Angeles, California
- +9 more
Sep 1, 2022
Disseminated Neuroblastoma, Ganglioneuroblastoma, Localized Resectable Neuroblastoma Trial in United States (drug, radiation,
Active, not recruiting
- Disseminated Neuroblastoma
- +5 more
- cyclophosphamide
- +18 more
-
Birmingham, Alabama
- +22 more
Mar 3, 2022
Ganglioneuroblastoma, Neuroblastoma Trial in Canada, Puerto Rico, United States (procedure, drug, biological, radiation)
Recruiting
- Ganglioneuroblastoma
- Neuroblastoma
- Autologous Hematopoietic Stem Cell Transplantation
- +18 more
-
Birmingham, Alabama
- +158 more
Sep 14, 2022
Ganglioneuroblastoma, Nodular, Neuroblastoma Trial in Worldwide (Dinutuximab, Irinotecan, Isotretinoin)
Active, not recruiting
- Ganglioneuroblastoma, Nodular
- Neuroblastoma
- Dinutuximab
- +4 more
-
Mesa, Arizona
- +77 more
Aug 17, 2022
Tumor Tissue Samples From Newly Diagnosed Neuroblastoma or
Recruiting
- Ganglioneuroblastoma
- +5 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +258 more
Mar 23, 2022
Rare Embryonal Tumors of Central Nervous System: International
Not yet recruiting
- Embryonal Tumor
-
Yerevan, ArmeniaHematology Center named after prof. R. Yeolyan
Jan 25, 2023
Congenital Central Hypoventilation Syndrome Trial in Chicago
Recruiting
- Congenital Central Hypoventilation Syndrome
-
Chicago, IllinoisAnn & Robert H. Lurie Children's Hospital of Chicago and the Sta
Aug 18, 2022
Childhood Brain Tumor Trial in Germany
Active, not recruiting
- Childhood Brain Tumor
-
Aachen, Germany
- +55 more
Apr 11, 2022
Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Worldwide (Carboplatin,
Recruiting
- Ganglioneuroblastoma
- +3 more
- Carboplatin
- +6 more
-
Birmingham, Alabama
- +219 more
Aug 17, 2022
Neuroblastoma Trial in France (Blood sampling)
Active, not recruiting
- Neuroblastoma
- Blood sampling
-
Amiens, France
- +26 more
May 18, 2021
LOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSES Trial in Worldwide (chemo)
Recruiting
- LOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSES
-
Graz, Austria
- +86 more
Oct 17, 2019
Neuroblastic Tumors Trial in Genova (survival and late effects)
Unknown status
- Neuroblastic Tumors
- survival and late effects
-
Genova, ItalyIstituto Giannina Gaslini
Jan 25, 2017
Neuroblastoma Trial in Canada, United States (biological, drug, procedure, radiation)
Completed
- Neuroblastoma
- filgrastim
- +14 more
-
Birmingham, Alabama
- +95 more
May 16, 2013